Long-term safety study of lunsekimig for nasal polyps
Treatments studied
Part of Ear, nose & throat clinical trials.
This study tests the long-term safety and effectiveness of a medication called lunsekimig for people with chronic sinusitis and nasal polyps. It is for those who already completed a previous study on this drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have finished a prior lunsekimig study for chronic sinusitis with nasal polyps, including the final visit.
- You need to use a prescription nasal spray (mometasone furoate) as part of your treatment.
- You must be willing and able to follow the study schedule and procedures.
- You should not have had a serious allergic reaction to lunsekimig or its ingredients before.
- You should not have had a side effect from lunsekimig in the earlier study that would make continued treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “biologic” medicines work in real-life care for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP). It may help confirm which patients benefit and how treatment is used in everyday practice.
This trial tests a new injection (SHR-1905) for people with chronic sinusitis and nasal polyps who still have symptoms despite using standard nasal spray treatments. It aims to see if the drug can reduce polyp size and improve symptoms.
This study tests a new medication called CM326 for people with long-term sinus inflammation and nasal polyps. The goal is to see if it reduces symptoms like congestion and improves quality of life. You will receive either the study drug or a placebo.
This study tests whether combining mepolizumab (a biologic injection) with a quick in-office removal of nasal polyps improves symptoms better than usual care. It is for adults with chronic sinusitis and nasal polyps who qualify for biologic therapy.
This study looks at blood and other measures (biomarkers) to understand how well mepolizumab helps people with nasal polyps, with or without asthma. It aims to find response clues that could help personalize treatment in the future.
This study is a long-term follow-up for people with COPD who have already completed an earlier lunsekimig study. It aims to check the safety and effectiveness of the treatment over a longer period.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.